AI vs. doctors: who makes better dialysis decisions?
NCT ID NCT07539428
First seen Apr 22, 2026 · Last updated Jun 23, 2026 · Updated 13 times
Summary
This study tests whether a special AI tool (called PD-LLM) can help doctors make better decisions for patients on peritoneal dialysis. 150 doctors will review made-up patient cases, some using the AI and some not. Researchers will compare how accurate and safe their treatment plans are, and how long they take.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL DIALYSIS (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sixiu Chen
Guangzhou, Guangdong, 510080, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Peritoneal dialysis-specialized large language model (PD-LLM)
What this could lead to
If successful, this could show that AI tools help doctors manage dialysis more accurately and safely, potentially improving patient outcomes.
What could go wrong
This is a small, early-stage study using hypothetical cases, not real patients. The AI might give wrong or harmful advice, and results may not apply to everyday clinical practice.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.